TrialBritish journal of clinical pharmacology2020

Effects of the dual sodium-glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure.

Rudolf A de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.